Satoyoshi E. Kinoshita M. Oculopharyngodistal myopathy. Arch Neurol. 1977;34:89–92.
Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, et al. Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology. 2011;76:227–35.
Kumutpongpanich T, Ogasawara M, Ozaki A, Ishiura H, Tsuji S, Minami N, et al. Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes. JAMA Neurol. 2021;78:853–63.
Ishiura H. Recent progress in oculopharyngodistal myopathy research from clinical and genetic viewpoints. J Neuromuscul Dis. 2025;12:303–11.
Eura N, Ogasawara M, Nishino I. Recent topics of oculopharyngodistal myopathy. Neurol Clin Neurosci. 2024;12:10–5.
Minami N, Ikezoe K, Kuroda H, Nakabayashi H, Satoyoshi E, Nonaka I. Oculopharyngodistal myopathy is genetically heterogeneous and most cases are distinct from oculopharyngeal muscular dystrophy. Neuromuscul Disord. 2001;11:699–702.
Eura N, Noguchi S, Ogasawara M, Kumutpongpanich T, Hayashi S, Nishino I. Characteristics of the muscle involvement along the disease progression in a large cohort of oculopharyngodistal myopathy compared to oculopharyngeal muscular dystrophy. J Neurol. 2023;270:5988–98.
Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, Tomé FM, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18:164–7.
Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51:1222–32.
Deng J, Yu J, Li P, Luan X, Cao L, Zhao J, et al. Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy. Am J Hum Genet. 2020;106:793–804.
Ogasawara M, Iida A, Kumutpongpanich T, Ozaki A, Oya Y, Konishi H, et al. CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun. 2020;8:204.
Yu J, Deng J, Guo X, Shan J, Luan X, Cao L, et al. The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. Brain. 2021;144:1819–32.
Yu J, Shan J, Yu M, Di L, Xie Z, Zhang W, et al. The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4. Am J Hum Genet. 2022;109:533–41.
Zeng YH, Yang K, Du GQ, Chen YK, Cao CY, Qiu YS, et al. GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy. Ann Neurol. 2022;92:512–26.
Gu X, Yu J, Jiao K, Deng J, Xia X, Qiao K, et al. Non-coding CGG repeat expansion in LOC642361/NUTM2B-AS1 is associated with a phenotype of oculopharyngodistal myopathy. J Med Genet. 2024;61:340–6.
Cortese A, Beecroft SJ, Facchini S, Curro R, Cabrera-Serrano M, Stevanovski I, et al. A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry. Nat Commun. 2024;15:6327.
Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905–14.
Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047–58.
Eura N, Noguchi S, Ogawa M, Sonehara K, Yamanaka A, Kurashige T, et al. Pathogenic CGG expansions in oculopharyngodistal myopathy exhibit distinct characteristics of each causative gene on the flanking sequences as well as methylation status. Genome Med. 2026;18:33.
Protic D, Hagerman R. State-of-the-art therapies for fragile X syndrome. Dev Med Child Neurol. 2024;66:863–71.
Hunter JE, Abramowitz A, Rusin M, Sherman SL. Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med. 2009;11:79–89.
Pongpakdee S, Apiwattanakul M, Termglinchan T, Witoonpanich R, Dejthevaporn C, Lee T, et al. CGG/CCG Repeat Expansions in LOC642361/NUTM2B-AS1 in Thai Patients With Oculopharyngodistal Myopathy. Neurol Genet. 2024;10:e200170.
Kume K, Kurashige T, Muguruma K, Morino H, Tada Y, Kikumoto M, et al. CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis. Am J Hum Genet. 2023;110:1086–97.
Hobara T, Ando M, Higuchi Y, Yuan JH, Yoshimura A, Kojima F, et al. Linking LRP12 CGG repeat expansion to inherited peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2025;96:140–9.
Nolin SL, Glicksman A, Tortora N, Allen E, Macpherson J, Mila M, et al. Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles. Am J Med Genet A. 2019;179:1148–56.
Zhao XN, Usdin K. The Repeat Expansion Diseases: The dark side of DNA repair. DNA Repair. 2015;32:96–105.
Groh M, Lufino MM, Wade-Martins R, Gromak N. R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet. 2014;10:e1004318.
Chen X, Mariappan SV, Moyzis RK, Bradbury EM, Gupta G. Hairpin induced slippage and hyper-methylation of the fragile X DNA triplets. J Biomol Struct Dyn. 1998;15:745–56.
Schmidt MHM, Pearson CE. Disease-associated repeat instability and mismatch repair. DNA Repair. 2016;38:117–26.
Mohren L, Erdlenbruch F, Leitao E, Kilpert F, Hones GS, Kaya S, et al. Identification and characterization of pathogenic and non-pathogenic FGF14 repeat expansions. Nat Commun. 2024;15:7665.
Pellerin D, Del Gobbo GF, Couse M, Dolzhenko E, Nageshwaran SK, Cheung WA, et al. A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus. Nat Genet. 2024;56:1366–70.
Yrigollen CM, Martorell L, Durbin-Johnson B, Naudo M, Genoves J, Murgia A, et al. AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J Neurodev Disord. 2014;6:24.
Liang Q, Liu Y, Liu Y, Duan R, Meng W, Zhan J, et al. Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing. Clin Chem. 2022;68:1529–40.
Boivin M, Deng J, Pfister V, Grandgirard E, Oulad-Abdelghani M, Morlet B, et al. Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: The polyG diseases. Neuron. 2021;109:1825–35.e5.
Hayward BE, Usdin K. Mechanisms of Genome Instability in the Fragile X-Related Disorders. Genes. 2021;12:1633.
Xie L, Li H, Xiao M, Chen N, Zang X, Liu Y, et al. Epigenetic insights into Fragile X Syndrome. Front Cell Dev Biol. 2024;12:1432444.
Huang G, Zhu H, Wu S, Cui M, Xu T. Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome. Front Genet. 2019;10:446.
Nakamori M, Thornton C. Epigenetic changes and non-coding expanded repeats. Neurobiol Dis. 2010;39:21–7.
Tassanakijpanich N, Hagerman RJ, Worachotekamjorn J. Fragile X premutation and associated health conditions: A review. Clin Genet. 2021;99:751–60.
Qurashi A, Li W, Zhou JY, Peng J, Jin P. Nuclear accumulation of stress response mRNAs contributes to the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet. 2011;7:e1002102.
Krans A, Skariah G, Zhang Y, Bayly B, Todd PK. Neuropathology of RAN translation proteins in fragile X-associated tremor/ataxia syndrome. Acta Neuropathol Commun. 2019;7:152.
Hoem G, Bowitz Larsen K, Øvervatn A, Brech A, Lamark T, et al. The FMRpolyGlycine Protein Mediates Aggregate Formation and Toxicity Independent of the CGG mRNA Hairpin in a Cellular Model for FXTAS. Front Genet. 2019;10:249.
Asamitsu S, Yabuki Y, Ikenoshita S, Kawakubo K, Kawasaki M, Usuki S, et al. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome. Sci Adv. 2021;7:eabd9440.